NCT03053765 is a NA clinical trial of training in IPT in Depression, sponsored by University of Iowa.

Who is sponsoring NCT03053765?

NCT03053765 is sponsored by University of Iowa.

What drugs are being tested in NCT03053765?

Interventions in NCT03053765: training in IPT.

What condition does NCT03053765 study?

NCT03053765 studies Depression.

Is NCT03053765 still recruiting?

NCT03053765 is currently terminated. Last updated 9 June 2022.

Last reviewed 2022-06-09 · How we verify

NCT03053765

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optimizing Fidelity of Interpersonal Psychotherapy

Terminated NA Last updated 9 June 2022

What this trial tests

NA trial testing training in IPT in Depression in 115 participants. Terminated before completion.

Timeline

3 August 2012

Primary endpoint
31 January 2020

31 January 2020

Quick facts

Lead sponsor	University of Iowa
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	115
Start date	3 August 2012
Primary completion	31 January 2020
Estimated completion	31 January 2020
Sites	1 location across United States

Drugs / interventions tested

training in IPT

Conditions studied

Depression — all drugs for Depression →

Sponsor

University of Iowa

Who can join

Adults 21 to 99, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to develop and validate an instrument to measure quality and adherence to IPT for research and training purposes. The measure is now being used to evaluate training in IPT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other University of Iowa trials

Trials by the same sponsor.

NCT07224269 — Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis · EARLY_PHASE1 · not yet recruiting
NCT07244809 — Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adve · NA · recruiting
NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
NCT06951594 — Robotic-Assisted Versus Manual Electrode Array Insertion · NA · recruiting
NCT06710119 — Effect of Custom Dynamic Orthoses on Forefoot Loading · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03053765 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Iowa
Last refreshed: 9 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03053765.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing